And to discuss more on all things Covid and vaccines, we're joined by Dr. Alice Tan, internist at MizMedi Women's Hospital.
Dr. Tan, it's great to have you on the show tonight.
Over the past month, with kindergarten through 12th grade in session in the U.S., the country reported almost 1 million cases among those under 18. Though kids have so far been typically less likely than adults to become severely ill with Covid.
What's causing the increase in cases among children?
Pfizer & BioNTech earlier this week reported strong outcomes in trials for 5-to-11-year-olds. But federal approval for the shots isn't expected until late October at the earliest.
As a medical expert, do you believe vaccinations are necessary for 5 to 11 year olds?
Vaccine advisers to the CDC argued long and hard before finally endorsing giving booster doses of Pfizer's Covid-19 vaccine to people 65 and older, long-term care facility residents and certain people with underlying conditions.
However, the advisers voted against recommending a booster dose for people whose jobs or situations put them at high risk of vaccine breakthrough infection rejecting part of the US Food and Drug Administration's emergency use authorization. Why the conflict between agencies here?
Meanwhile, during President Moon's trip to New York earlier this week, U.S. bioprocess vendor Cytiva pledged a 52-and-a-half million dollar investment plan in Korea' vaccine production.
What does this mean for the nation's ambition to become a global vaccine hub and and in contributing to more equitable access of vaccines to countries in need?
Dr. Alice Tan, thanks as always for your insights and expertise.